BIONIK LABORATORIES CORP.: 10-K filed 2021-06-24
What BIONIK LABORATORIES CORP. reported in its annual report filed 2021-06-24 (fiscal FY 2021): 45 published measures, 94 facts as tagged in accession 0001104659-21-084897.
This filing
- Form
- 10-K (annual report)
- Filed
- 2021-06-24
- Fiscal period
- fiscal FY 2021
- Accession
- 0001104659-21-084897 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 8,786,085 | USD | |
| At 2020-03-31 | 18,516,620 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 5,505,055 | USD | |
| At 2020-03-31 | 5,199,645 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 3,281,030 | USD | |
| At 2020-03-31 | 13,316,975 | USD | |
| At 2019-03-31 | 27,407,933 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 608,348 | USD | |
| At 2020-03-31 | 2,269,747 | USD | |
| At 2019-03-31 | 446,779 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -13,620,457 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -25,016,497 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -4,623,886 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -9,063,554 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 0 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 159,645 | USD | 366 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,193,430 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 2,153,354 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 2,962,487 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 11,046,167 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 0 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -159,645 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | -84,994,327 | USD | |
| At 2020-03-31 | -71,373,870 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 0 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 0 | USD | 366 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 93,577 | USD | |
| At 2020-03-31 | 154,144 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 819,213 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 1,781,612 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -13,337,325 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -25,086,942 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 3,432,973 | USD | |
| At 2020-03-31 | 5,826,568 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 405,279 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 181,914 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 4,095,164 | USD | |
| At 2020-03-31 | 4,784,019 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 454,809 | USD | |
| At 2020-03-31 | 857,093 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 4,282,984 | USD | |
| At 2020-12-31 | 4,300,000 | USD | |
| At 2020-03-31 | 11,085,984 | USD | |
| At 2019-03-31 | 22,308,275 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 451,905 | USD | |
| At 2020-03-31 | 846,964 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 14,261,123 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 26,346,922 | USD | 366 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 692,163 | USD | |
| At 2020-03-31 | 1,059,462 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 923,798 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 1,259,980 | USD | 366 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 269,632 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 893,374 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,491,747 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 3,889,461 | USD | 366 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 88,227,506 | USD | |
| At 2020-03-31 | 84,643,570 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 42,149 | USD | |
| At 2020-03-31 | 42,149 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 679,135 | USD | |
| At 2020-03-31 | 644,292 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 585,558 | USD | |
| At 2020-03-31 | 490,148 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 976,551 | USD | |
| At 2020-03-31 | 1,449,924 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 760,026 | USD | |
| At 2020-03-31 | 1,647,656 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 1,680,557 | USD | |
| At 2020-03-31 | 1,632,555 | USD |
Current contract liabilities
Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 268,083 | USD | |
| At 2020-03-31 | 200,437 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 15,418,478 | USD | |
| At 2020-03-31 | 12,349,308 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -13,620,457 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -25,016,497 | USD | 366 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -13,620,457 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -25,016,497 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 3,750,457 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 4,580,046 | USD | 366 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 100,000 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 100,000 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 189,730 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 380,646 | USD | 366 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,524,560 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 1,430,240 | USD | 366 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -283,132 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 70,445 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -395,059 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -508,729 | USD | 366 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -332,456 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 653,780 | USD | 366 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -407,875 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -291,759 | USD | 366 |
Inspect the source
- Entity
- BIONIK LABORATORIES CORP. / CIK 0001508381
- Captured
- SEC response SHA-256
5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))